Delivery Order SPE2DB20D3101-SPE2DB25FRWE5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,541.99 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is an antiretroviral combination therapy used for HIV treatment,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,675.06 firm fixed-price delivery order for TRIUMEQ 600-50-300 mg tablets (30-unit pack) to be delivered to Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA Troop Support Medical. TRIUMEQ is an antiretroviral combination medication used in HIV...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Triumeq 600-50-300 mg tablets (30-count units) valued at $3,625.03. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,519.84 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger federal contract vehicle. This award falls under AmerisourceBergen's significant...
- The Defense Logistics Agency awarded a $11,096.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with a completion date of August 4, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026. The delivery will be performed...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,855.22 on September 4, 2025, for the supply of Triumeq 600-50-300 mg tablets in quantities of 30 units. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This...
- The Defense Logistics Agency awarded a $18,696.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with an ultimate completion date of August 25, 2025. This non-set-aside competitive award was issued on August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $13,139.28 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with an ultimate completion date of September 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. TRIUMEQ is an antiretroviral combination medication used in HIV treatment, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30s, with a ceiling value of $6,519.84 and an ultimate completion date of August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $33,210.45 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. The contract employs firm fixed pricing and is classified as a non-set-aside competitive award, with an ultimate completion date of August 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWE5Delivery Order
The Defense Logistics Agency awarded a $6,519.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Triumeq 600-50-300 mg tablets, a combination antiretroviral medication used in HIV treatment. This non-set-aside competitive award was issued on September 22, 2025, with an ultimate completion date of September 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. As a major pharmaceutical distributor and critical vendor for federal healthcare systems, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical supplies to support military and veteran healthcare programs globally. The parent IDC enables the company to fulfill pharmaceutical needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's established capability to meet federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 9/22/25 |